Showing results (531-540 of 12,170) with videos related to
Sort By:
Pageof 1,217
Journal of Cardiovascular Pharmacology|March 1, 1996
Therapeutic, but not low-dose, angiotensin-converting enzyme inhibition causes regression of cardiovascular changes in spontaneously hypertensive ratsH Wahlander, M Sohtell, A Wickman, et al.Journal of Cardiovascular Pharmacology|March 1, 1996
Effects of thapsigargin and cyclopiazonic acid on intracellular calcium activity in newborn rat cardiomyocytes during their development in primary cultureJ P Gomez, D PotreauJournal of Cardiovascular Pharmacology|March 1, 1996
Vasoconstrictor function of the rat isolated perfused mesenteric arterial bed seven days after hypophysectomyV Ralevic, M Afework, G BurnstockJournal of Cardiovascular Pharmacology|March 1, 1996
Simvastatin releases Ca2+ from a thapsigargin-sensitive pool and inhibits InsP3-dependent Ca2+ mobilization in vascular smooth muscle cellsN Escobales, M Castro, P I Altieri, et al.Journal of Cardiovascular Pharmacology|March 1, 1996
Indapamide is as effective as captopril in the control of microalbuminuria in diabetesL M Molyneaux, K A Willey, D K YueJournal of Cardiovascular Pharmacology|January 1, 1996
Future management of high blood pressureC I JohnstonJournal of Cardiovascular Pharmacology|September 1, 1996
N-Acetylcysteine potentiates nitroglycerin-induced reversal of platelet aggregationY Y Chirkov, J D HorowitzJournal of Cardiovascular Pharmacology|September 1, 1996
Cardiovascular and renal effects of endothelin B receptor selective agonists in spontaneously hypertensive ratsJ E Bird, M R GiancarliJournal of Cardiovascular Pharmacology|September 1, 1996
Interactions of nonpeptide angiotensin II receptor antagonists at imidazoline/guanidinium receptor sites in rat forebrainZ Li, S M Bosch, T L Smith, et al.Journal of Cardiovascular Pharmacology|September 1, 1996
Evidence of systemic neuropeptide Y release after carbachol administration into the posterior hypothalamic nucleusJ R MartinPageof 1,217